Home LiteratureArticle Details
PMID: 7691885 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

The Journal of clinical investigation ·Vol. 92 ·No. 4 ·1993-10-00 ·Pages 1736-44

Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y

Abstract

The c-kit proto-oncogene encodes a receptor tyrosine kinase. Binding of c-kit ligand, stem cell factor (SCF) to c-kit receptor (c-kitR) is known to activate c-kitR tyrosine kinase, thereby leading to autophosphorylation of c-kitR on tyrosine and to association of c-kitR with substrates such as phosphatidylinositol 3-kinase (PI3K). In a human mast cell leukemia cell line HMC-1, c-kitR was found to be constitutively phosphorylated on tyrosine, activated, and associated with PI3K without the addition of SCF. The expression of SCF mRNA transcript in HMC-1 cells was not detectable by means of PCR after reverse transcription (RT-PCR) analysis, suggesting that the constitutive activation of c-kitR was ligand independent. Sequencing of whole coding region of c-kit cDNA revealed that c-kit genes of HMC-1 cells were composed of a normal, wild-type allele and a mutant allele with two point mutations resulting in intracellular amino acid substitutions of Gly-560 for Val and Val-816 for Asp. Amino acid sequences in the regions of the two mutations are completely conserved in all of mouse, rat, and human c-kit. In order to determine the causal role of these mutations in the constitutive activation, murine c-kit mutants encoding Gly-559 and/or Val-814, corresponding to human Gly-560 and/or Val-816, were constructed by site-directed mutagenesis and expressed in a human embryonic kidney cell line, 293T cells. In the transfected cells, both c-kitR (Gly-559, Val-814) and c-kitR (Val-814) were abundantly phosphorylated on tyrosine and activated in immune complex kinase reaction in the absence of SCF, whereas tyrosine phosphorylation and activation of c-kitR (Gly-559) or wild-type c-kitR was modest or little, respectively. These results suggest that conversion of Asp-816 to Val in human c-kitR may be an activating mutation and responsible for the constitutive activation of c-kitR in HMC-1 cells.

Related Genes
MeSH Terms
Amino Acid Sequence Animals Base Sequence Cell Line DNA Primers Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology Humans Interleukin-3/pharmacology Leukemia, Mast-Cell/genetics Mice Molecular Sequence Data Phosphotyrosine Point Mutation Polymerase Chain Reaction Proto-Oncogene Mas Proto-Oncogene Proteins/biosynthesis,genetics,metabolism Proto-Oncogene Proteins c-kit Proto-Oncogenes Receptor Protein-Tyrosine Kinases/biosynthesis,genetics,metabolism Receptors, Colony-Stimulating Factor/biosynthesis,genetics,metabolism Recombinant Proteins/pharmacology Transfection Tumor Cells, Cultured Tyrosine/analogs & derivatives,analysis
Chemicals
DNA Primers Interleukin-3 MAS1 protein, human Proto-Oncogene Mas Proto-Oncogene Proteins Receptors, Colony-Stimulating Factor Recombinant Proteins Phosphotyrosine Tyrosine Granulocyte-Macrophage Colony-Stimulating Factor Proto-Oncogene Proteins c-kit Receptor Protein-Tyrosine Kinases
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Furitsu T
Second Department of Internal Medicine, Osaka University Medical School, Suita, Japan.
Tsujimura T
Tono T
Ikeda H
Kitayama H
Koshimizu U
Sugahara H
Butterfield J H
Ashman L K
Kanayama Y
References (59)
59 references, click to expand
  1. Preferential expression of c-kit protooncogene transcripts in small cell lung cancer.
    Cancer Res. 1991 May 1;51(9):2416-9 PMID: 1707753
  2. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors.
    Blood. 1992 Sep 1;80(5):1199-206 PMID: 1381238
  3. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.
    Science. 1991 May 3;252(5006):668-74 PMID: 1708916
  4. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.
    Blood. 1991 May 15;77(10):2142-9 PMID: 1709371
  5. The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor.
    Mol Cell Biol. 1991 Jun;11(6):3043-51 PMID: 1710023
  6. A new technique for the assay of infectivity of human adenovirus 5 DNA.
    Virology. 1973 Apr;52(2):456-67 PMID: 4705382
  7. Characteristics of a human cell line transformed by DNA from human adenovirus type 5.
    J Gen Virol. 1977 Jul;36(1):59-74 PMID: 886304
  8. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  9. Hereditary anemias of the mouse: a review for geneticists.
    Adv Genet. 1979;20:357-459 PMID: 390999
  10. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 PMID: 3881765
  11. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family.
    Nature. 1986 Apr 3-9;320(6061):415-21 PMID: 3007997
  12. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo.
    Am J Pathol. 1987 Apr;127(1):191-8 PMID: 3551622
  13. Establishment of an immature mast cell line from a patient with mast cell leukemia.
    Leuk Res. 1988;12(4):345-55 PMID: 3131594
  14. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
    Science. 1988 Jul 1;241(4861):42-52 PMID: 3291115
  15. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.
    EMBO J. 1988 Apr;7(4):1003-11 PMID: 2456920
  16. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features.
    Br J Haematol. 1988 Jul;69(3):359-66 PMID: 3261598
  17. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.
    Nature. 1988 Sep 1;335(6185):88-9 PMID: 2457811
  18. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene.
    Cell. 1988 Oct 7;55(1):185-92 PMID: 2458842
  19. Growth factor receptor tyrosine kinases.
    Annu Rev Biochem. 1988;57:443-78 PMID: 3052279
  20. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype.
    Cell. 1988 Dec 23;55(6):965-77 PMID: 2849512
  21. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential.
    Cell. 1988 Dec 23;55(6):979-88 PMID: 2974321
  22. c-kit protein, a transmembrane kinase: identification in tissues and characterization.
    Mol Cell Biol. 1988 Nov;8(11):4896-903 PMID: 2463468
  23. Heterogeneity of mast cells and phenotypic change between subpopulations.
    Annu Rev Immunol. 1989;7:59-76 PMID: 2653378
  24. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice.
    Genes Dev. 1989 Jun;3(6):816-26 PMID: 2473008
  25. c-kit mRNA expression in human and murine hematopoietic cell lines.
    Oncogene. 1989 Aug;4(8):1047-9 PMID: 2474787
  26. The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia.
    Leukemia. 1989 Oct;3(10):699-702 PMID: 2476640
  27. Development of human mast cells in vitro.
    Proc Natl Acad Sci U S A. 1989 Dec;86(24):10039-43 PMID: 2532357
  28. Signal transduction by receptors with tyrosine kinase activity.
    Cell. 1990 Apr 20;61(2):203-12 PMID: 2158859
  29. Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins.
    Blood. 1990 Aug 15;76(4):706-15 PMID: 2166606
  30. Identification of a ligand for the c-kit proto-oncogene.
    Cell. 1990 Oct 5;63(1):167-74 PMID: 1698553
  31. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles.
    Cell. 1990 Oct 5;63(1):175-83 PMID: 1698554
  32. Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.
    Cell. 1990 Oct 5;63(1):195-201 PMID: 2208278
  33. Primary structure and functional expression of rat and human stem cell factor DNAs.
    Cell. 1990 Oct 5;63(1):203-11 PMID: 2208279
  34. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor.
    Cell. 1990 Oct 5;63(1):213-24 PMID: 1698556
  35. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.
    Cell. 1990 Oct 5;63(1):225-33 PMID: 1698557
  36. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.
    Cell. 1990 Oct 5;63(1):235-43 PMID: 1698558
  37. Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors.
    EMBO J. 1990 Oct;9(10):3287-94 PMID: 1698611
  38. Phorbol 12-myristate 13-acetate inhibits granulocyte-macrophage colony stimulating factor-induced protein tyrosine phosphorylation in a human factor-dependent hematopoietic cell line.
    J Biol Chem. 1991 Jan 5;266(1):490-5 PMID: 1845978
  39. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.
    Exp Hematol. 1991 Mar;19(3):226-31 PMID: 1704845
  40. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors.
    Cancer Res. 1991 Apr 1;51(7):1811-6 PMID: 1706218
  41. Expression and function of c-kit in hemopoietic progenitor cells.
    J Exp Med. 1991 Jul 1;174(1):63-71 PMID: 1711568
  42. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow.
    Blood. 1991 Jul 1;78(1):30-7 PMID: 1712644
  43. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase.
    EMBO J. 1991 Sep;10(9):2451-9 PMID: 1714377
  44. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile.
    Blood. 1991 Sep 15;78(6):1403-12 PMID: 1715789
  45. Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene.
    Blood. 1991 Oct 15;78(8):1942-6 PMID: 1912577
  46. Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro.
    J Cell Physiol. 1991 Sep;148(3):503-9 PMID: 1717499
  47. Proliferation of human myeloid leukemia cell line associated with the tyrosine-phosphorylation and activation of the proto-oncogene c-kit product.
    Blood. 1991 Dec 1;78(11):2834-40 PMID: 1720036
  48. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells.
    Blood. 1991 Dec 1;78(11):2962-8 PMID: 1720040
  49. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
    Leukemia. 1991 Oct;5(10):854-60 PMID: 1720490
  50. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
    J Immunol. 1991 Dec 15;147(12):4224-8 PMID: 1721642
  51. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture.
    Blood. 1992 Nov 1;80(9):2237-45 PMID: 1384799
  52. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand.
    Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):735-9 PMID: 7678463
  53. Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutation.
    Blood. 1993 May 15;81(10):2530-8 PMID: 7683920
  54. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
    EMBO J. 1987 Nov;6(11):3341-51 PMID: 2448137
  55. Basophil and mast cell lineages in vitro and in vivo.
    Blood. 1992 Feb 15;79(4):846-60 PMID: 1737095
  56. Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III.
    Oncogene. 1992 Apr;7(4):685-91 PMID: 1373482
  57. Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene.
    Blood. 1992 Jun 15;79(12):3145-58 PMID: 1350740
  58. Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor.
    Blood. 1992 Jul 1;80(1):60-7 PMID: 1377054
  59. Monoclonal antibody YB5.B8 identifies the human c-kit protein product.
    Blood. 1991 May 1;77(9):1876-83 PMID: 1708291
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1993-10-00
Pages
1736-44
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC288334
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com